Log In
BCIQ
Print this Print this
 

Hereditary Cancer Syndromes Test, Multi-Gene Hereditary Cancer Test

  Manage Alerts
Collapse Summary General Information
Company Invitae Corp.
DescriptionNext-generation sequencing (NGS)-based 34-gene hereditary cancer panel
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetermine risk of hereditary breast and ovarian cancer; Risk assessment of breast/ovarian cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today